Cyproterone acetate, ethinyl estradiol drug combination
Showing 26 - 50 of >10,000
Hiv, Transgenderism Trial in Toronto (Biktarvy 50/200/25 Tab, Estradiol Tablets)
Recruiting
- Hiv
- Transgenderism
- Biktarvy 50/200/25 Tab
- Estradiol Tablets
-
Toronto, Ontario, CanadaMaple Leaf Research
Dec 15, 2022
Pelvic Pain Trial in Hangzhou (Aspirin, Drospirenone ethinyl estradiol)
Recruiting
- Pelvic Pain
- Aspirin
- Drospirenone ethinyl estradiol
-
Hangzhou, Zhejiang, ChinaWomen's Hospital School of Medicine Zhejiang University
Jan 20, 2022
Uterine Fibroids, Heavy Menstrual Bleeding Trial in Canada, United States (Elagolix, Placebo for Estradiol/Norethindrone
Completed
- Uterine Fibroids
- Heavy Menstrual Bleeding
- Elagolix
- +3 more
-
Birmingham, Alabama
- +104 more
Jul 9, 2021
Endometriosis, Moderate to Severe Endometriosis-associated Pain Trial (BG2109 100mg, BG2109 200mg, ABT(E2 1 mg / NETA 0.5 mg))
Not yet recruiting
- Endometriosis
- Moderate to Severe Endometriosis-associated Pain
- BG2109 100mg
- +5 more
- (no location specified)
Jun 6, 2023
Hyperandrogenism, Metabolic Cardiovascular Syndrome Trial in Madrid (Phlebotomy, ethinylestradiol, Cyproterone Acetate)
Completed
- Hyperandrogenism
- Metabolic Cardiovascular Syndrome
- Phlebotomy
- +2 more
-
Madrid, SpainDiabetes, Obesity and Human Reproduction Research Group, Departm
Jul 25, 2022
Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial in Worldwide (Abiraterone Acetate, Prednisone,
Active, not recruiting
- Prostatic Neoplasms
- Metastatic Castration-Resistant Prostate Cancer
- Abiraterone Acetate
- +2 more
-
Los Angeles, California
- +6 more
Jan 18, 2023
Metrorrhagia, Pelvic Pain, Menorrhagia Trial in United States (Myfembree Oral Product)
Not yet recruiting
- Metrorrhagia
- +3 more
- Myfembree Oral Product
-
Chicago, Illinois
- +5 more
Sep 12, 2022
Healthy Postmenopausal Females Trial (Commercial NOMAC-E2, Phase 3 NOMAC-E2 "Batch A", Phase 3 NOMAC-E2 "Batch B")
Completed
- Healthy Postmenopausal Females
- Commercial NOMAC-E2
- +2 more
- (no location specified)
Feb 7, 2022
Contraception Trial in Portland (Cannabidiol Oil, Placebo, Combined oral contraceptive pill)
Active, not recruiting
- Contraception
- Cannabidiol Oil
- +2 more
-
Portland, OregonOHSU
Mar 31, 2022
Bioequivalence Trial in Santiago (Levonorgestrel 15.0 mg and Ethinyl estradiol 0.03 mg Test Drug, Levonorgestrel 15.0 mg and
Completed
- Bioequivalence
- Levonorgestrel 15.0 mg and Ethinyl estradiol 0.03 mg Test Drug
- Levonorgestrel 15.0 mg and Ethinyl estradiol 0.03 mg Reference Product
-
Santiago, ChileInnolab
Feb 8, 2021
Anemia Trial (Measure hemoglobin)
Not yet recruiting
- Anemia
- Measure hemoglobin
- (no location specified)
Oct 6, 2022
Androcur® and Meningioma Development:Genotype-environment
Recruiting
- Meningioma
- oral smears
-
Boulogne-Billancourt, FranceEndocrinology Nutrition Department, Ambroise Paré Hospital, APHP
Sep 27, 2021
Transgender Health, Gender Dysphoria, Transgender Women Trial in Philadelphia (Doravirine/Lamivudine/Tenofovir, Spironolactone
Completed
- Transgender Health
- +3 more
- Doravirine/Lamivudine/Tenofovir
- +3 more
-
Philadelphia, PennsylvaniaClinical Research Unit at Thomas Jefferson University
Feb 1, 2023
Healthy Trial in Hialeah (Relugolix/E2/NETA FDC, Relugolix, Erythromycin)
Completed
- Healthy
- Relugolix/E2/NETA FDC
- +2 more
-
Hialeah, FloridaClinical Pharmacology of Miami, An Evolution Research Group Port
Aug 30, 2021
Contraception Trial (Levonorgestrel/Ethinyl Estradiol)
Withdrawn
- Contraception
- Levonorgestrel/Ethinyl Estradiol
- (no location specified)
Aug 17, 2021
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- Abiraterone Acetate/Niraparib
- +5 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jan 9, 2023
Metastatic Breast Cancer Trial (Olaparib, 17b-estradiol)
Not yet recruiting
- Metastatic Breast Cancer
- (no location specified)
Jun 2, 2023
Polycystic Ovary Syndrome Trial in San Francisco (Yasmin)
Completed
- Polycystic Ovary Syndrome
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jan 6, 2023
Hiv, Prophylaxis, Transgender Trial in Baltimore (Truvada alone, Truvada plus Leuprolide, Truvada plus Estradiol 1 mg)
Recruiting
- Hiv
- +2 more
- Truvada alone
- +4 more
-
Baltimore, MarylandJohns Hopkins School of Medicine Drug Development Unit
Mar 8, 2022
Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma Trial
Not yet recruiting
- Locally Advanced Salivary Gland Carcinoma
- +3 more
- Biopsy
- +3 more
- (no location specified)
Jan 10, 2023
Uterine Fibroids, Endometriosis Trial (Relugolix Combination Tablet)
Not yet recruiting
- Uterine Fibroids
- Endometriosis
- Relugolix Combination Tablet
- (no location specified)
May 16, 2023